Scientists are reporting promising results for a new drug to treat COVID-19. The drug is known as EIDD-2801. It works by interfering with the coronavirus’ ability to make copies of itself once it infects a cell.
In that regard it’s similar to remdesivir, a drug currently being tested in COVID-19 patients. Researchers from Emory University in Atlanta; the University of North Carolina at Chapel Hill; and Vanderbilt University Medical Center in Nashville, first tested EIDD-2801 in cells cultured in the laboratory.